In vitro schistosomicidal activity of the lignan (−)-6,6′-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni

References

• Aftabrouchad C, Doelker E. 1992. Preparation methods for biodegradable microparticles loaded with water-soluble drugs. STP Pharma Sci. 2:365–380.
   Google Scholar
• Allam G, Ewas AF, AbueIsaad AS. 2013. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni. Parasitol Res. 112:3137–3149.
   PubMed Web of Science ®Google Scholar
• Bae SE, Son JS, Park K, Han DKJ. 2009. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Control Release. 133:37–43.
   PubMed Web of Science ®Google Scholar
• Barreiro EJ, Fraga AM. 2001. Química medicinal: as bases moleculares da Ação dos Fármacos. Porto Alegre (Brasil): Artmed Press.
   Google Scholar
• Bastos JK, Albuquerque S, Silva MLA. 1999. Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med. 65:541–544.
   PubMed Web of Science ®Google Scholar
• Costa PRR. 2000. Safrol e eugenol: estudo da reatividade química e uso em síntese de produtos naturais biologicamente ativos e seus derivados. Quím Nova. 23:357–369.
   Google Scholar
• Chen P, Wu QS, Ding YP, Chu M, Huang ZM, Hu W. 2010. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro. Eur J Pharm Biopharm. 76:413–420.
   PubMed Web of Science ®Google Scholar
• Da Silva R, De Souza GHB, Da Silva AAF, De Souza VA, Pereira AC, Royo VA, Silva MLA, Donate PM, Araujo ALSM, Carvalho JCT, et al. 2005. Synthesis and biological activity evaluation of lignan lactones derived from (-)-cubebin. Bioorg Med Chem Lett. 15:1033–1043.
   PubMed Web of Science ®Google Scholar
• De Araújo SC, De Mattos ACA, Teixeira HF, Coelho PMZ, Nelson DL, De Oliveira MC. 2007. Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions. Int J Pharm. 337:307–315.
   PubMed Web of Science ®Google Scholar
• Doshi N, Mitragotri N. 2009. Designer biomaterials for nanomedicine. Adv Funct Mater. 19:3843–3854.
   Web of Science ®Google Scholar
• Durán N, Durán M, Tasic L, Marcato PD. 2010. Tecnologia de nanocristais em fármacos. Quím Nova. 33:151–158.
   Google Scholar
• Faraji AH, Wipf P. 2009. Nanoparticles in cellular drug delivery. Bioorg Med Chem. 17:2950–2962.
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JPH, Ammoury N, Benita S, 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 55:R1–R4.
   Web of Science ®Google Scholar
• Freitas TC, Jung E, Pearce EJ. 2007. TGF-beta signaling controls embryo development in the parasitic flatworm. Schistosoma mansoni. PLOS Pathog. 3:489–502.
   Web of Science ®Google Scholar
• Ilium L, Davis S, Wilson C, Thomas N, Frier M, Hardy J. 1982. Blood clearance and organ deposition of intravenously administered colloidal particles. Int J Pharm. 12:135–146.
   Google Scholar
• Jeng KCG, Hou RCW. 2005. Sesamin anda sesamolin: nature’s therapeutic lignans. Cei. 10:11–20.
   Google Scholar
• Langer R. 1990. New methods of drug delivery. Science. 249:1527–1533.
   PubMed Web of Science ®Google Scholar
• Luz PP, Magalhães LG, Pereira AC, Cunha WR, Rodrigues V, Silva MLA. 2012. Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity. Parasitol Res. 110:593–598.
   PubMedGoogle Scholar
• Madaswamy MS, Manoj RK, Mishra A, Singh S. 2009. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomed Nanotechnol. 5:323–333.
   PubMed Web of Science ®Google Scholar
• Magalhães LG, De Souza JM, Wakabayashi KA, Laurentiz RS, Vinhólis AHC, Rezende KCS, Simaro GV, Bastos JK, Rodrigues V, Esperandim VR, et al. 2012. In vitro efficacy of the essential oil of Piper cubeba L. (Piperaceae) against Schistosoma mansoni. Parasitol Res. 110:1747–1754.
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Lahann J. 2009. Physical approaches to biomaterial design. Nat Mater. 8:15–23.
   PubMed Web of Science ®Google Scholar
• Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EHO. 2008. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther. 16:1450–1458.
   PubMed Web of Science ®Google Scholar
• Nassar EJ, Ciuffi KJ, Calefi PS, Rocha LA, De Faria EH, Silva MLA, Luz PP, Bandeira LC, Cestari A, Fernandes CN. 2011. Biomaterials and Sol-Gel process: a methodology for the preparation of functional materials. In: Pignatello R, editor. Biomaterials science and engineering. Vol 1. Rijeka: InTech Press; p. 3.
   Google Scholar
• Nair LS, Laurencin CTO. 2006. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Engin/Biotechnol. 102:47–90.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Gragg GM, Snader KM. 2003. Journal Natural Products as sources of new drugs over the period 1981-2002. J Nat Prod. 66:1022–1037.
   PubMed Web of Science ®Google Scholar
• Oliveira AR, Molina EF, Mesquita PC, Fonseca JLC, Rossanezi G, Pedrosa MFF, Oliveira AG, da Silva Júnior AAO. 2013. Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles. J Therm Anal Calorim. 112:555–565.
   Web of Science ®Google Scholar
• Puisieux L, Roblot-Treupel L. 1989. Vectorisation et vecteurs de médicaments. S T P Pharma 5:107–113.
   Google Scholar
• Pankhurst QA, Connoly J, Jones SK, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 36:167–181.
   Web of Science ®Google Scholar
• Pereira AC, Silva ML, Souza JM, Laurentiz RS, Rodrigues V, Januário AH, Pauletti PM, Tavares DC, Filho AA, Cunha WR, et al. 2015. In vitro and in vivo anthelmintic activity of (-)-6,6'-dinitrohinokinin against schistosomula and juvenile and adult worms of Schistosoma mansoni. Acta Trop. 149:195–201.
   PubMed Web of Science ®Google Scholar
• Rajeev AJ, Rodees CT, Railkar AM, Malick AW, Shah NH. 2000. Controlled release of drugs from injectable in situ formed biodegradable PLGA microespheres: effect of various formulation variables. J Pharmacokinet Biop. 50:257–262.
   Google Scholar
• Rejman J, Oberle V, Zuhorn I, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 377:159–169.
   PubMed Web of Science ®Google Scholar
• Saraiva J, Lira AAM, Esperandim VR, Ferreira DS, Ferraudo AS, Bastos JK, Silva MLA, Gaitani CM, Albuquerque S, Marchetti JM. 2010. (-)-Hinokinin-loaded poly (d,l-lactide-co-glycolide) microparticles for Chagas disease. Parasitol Res. 106:703–708.
   PubMed Web of Science ®Google Scholar
• Saravanakumar G, Jo DG, Park JH. 2012. Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging. Curr Med Chem. 19:3212–3229.
   PubMed Web of Science ®Google Scholar
• Setchell KD, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DM, Kirk DN, Adlercreatz H, Anderson LC, Axelson M. 1981. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet. 2:4–7.
   PubMed Web of Science ®Google Scholar
• Silva MLA, Coimbra HS, Pereira AC, Almeida VA, Lima TC, Costa ES, Vinhólis AHC, Royo VA, Silva R, Filho AAS, et al. 2007. Evaluation of Piper cubeba extracts, (-)-cubebin and semi-synthetic derivatives against oral pathogens. Phytother Res. 21:420–422.
   PubMed Web of Science ®Google Scholar
• Silva MLA, Rodrigues V, Albuquerque S, Bastos JK, Silva R, Pereira Júnior OS, Bianco TNC, Cunha WR, Santos FF, Donate PM, et al. 2009. In vitro schistosomicidal activity of (-)-6,6′-dinitrohinokinin: a semi-synthetic lignan derivative obtained from (-)-hinokinin. Planta Med. 75:945–945.
   Web of Science ®Google Scholar
• Souza VA, Silva R, Pereira AC, Royo VA, Saraiva J, Montanheiro M, Souza GHB, Da Silva Filho AA, Grando MD, Donate PM, et al. 2005. Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett. 15:303–307.
   PubMed Web of Science ®Google Scholar
• Smithers SR, Terry RJ. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695–700.
   PubMed Web of Science ®Google Scholar
• Xiao SH, Keiser J, Chollet J, Utzinger J, Dong Y, Endriss Y, Vennerstrom JL, Tanner M. 2007. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother. 51:1440–1445.
   PubMed Web of Science ®Google Scholar
• Yoo J-W, Doshi N, Mitragotri S. 2011. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliver. Rev. 63:1247–1256.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ko NR, Oh JK. 2012. Recent advances in stimuli-responsive degradable block copolymer micelles: synthesis and controlled drug delivery applications. Chem Commun (Camb). 48:7542–7552.
   PubMed Web of Science ®Google Scholar
• Ward RS. 1999. Lignans, neolignans and related compounds. Nat Prod Rep. 16:75–96.
   Web of Science ®Google Scholar